3M stock raises Eurobond funding as guidance and analyst upgrades support valuation
Published on 09/13/2026 at 14:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
3M Company stock (ISIN US88579Y1010) is drawing renewed investor attention after the diversified industrial group raised about EUR 1 billion in Eurobonds while its shares continue to trade below several fair-value estimates as of September 13, 2026. The funding move comes on the heels of stronger second-quarter 2026 results and a higher earnings guidance range for 2026.
Eurobond issue and valuation debate
According to Dealroom on September 13, 2026, 3M has raised roughly EUR 1 billion through fixed-rate Eurobonds, adding long-term funding in the European market while its stock is described as trading below estimated fair value. The same overview notes that one widely followed valuation model puts 3M’s fair value at about USD 181.85 per share versus a last close cited around USD 164.97, implying that the stock trades roughly 10.3 percent below this specific fair-value estimate.
This gap between trading price and modeled fair value is an important reference point for investors assessing whether the new Eurobond funding could be used to support growth investments, balance sheet flexibility or potential refinancing. The data also highlight recent share-price performance: Dealroom reports that 3M’s one-month share price return was down 9.68 percent, while the 90-day return was up 4.26 percent as of its September 13, 2026 snapshot, indicating short-term pressure but a moderately positive three-month trend.
Q2 2026 earnings and raised guidance
The current valuation discussion is anchored in tangible operating momentum from 3M’s latest quarterly results. As Stocktwits reported on September 12, 2026, 3M generated USD 6.5 billion in revenue in its fiscal second quarter of 2026, up from consensus expectations of USD 6.4 billion, while earnings per share came in at USD 2.40 compared with analysts’ consensus of USD 1.98. That means quarterly revenue exceeded expectations by about USD 0.1 billion and EPS beat the consensus by USD 0.42, a material positive surprise.
In addition, the same report cites that 3M delivered approximately 5.4 percent organic growth in Q2 2026, underscoring a tangible acceleration in underlying demand compared with prior periods. On top of the quarterly beat, 3M raised its adjusted EPS outlook for the full year 2026 to a range of USD 8.80 to USD 8.95 from a previous band of USD 8.50 to USD 8.70, marking an increase of up to USD 0.45 per share at the top end of guidance. For investors, this higher guidance range is a central data point that connects the Eurobond funding to a clearer multi-year growth and profitability narrative.
Analyst price targets move higher
Following the Q2 2026 earnings beat and guidance raise, several major Wall Street houses have updated their views on 3M stock, providing additional context for the current valuation. According to Stocktwits, Goldman Sachs raised its price target on 3M to USD 202 from USD 190 while reiterating a Buy rating, pointing to stronger Q2 results, efficiency improvements and a growing product pipeline. UBS increased its target to USD 218 from USD 190 and kept a Buy rating, implying roughly 28 percent upside versus the cited recent closing price, signaling confidence in 3M’s ability to execute on its strategy.
Not all analyst commentary is uniformly bullish, which gives investors a more nuanced picture. The same Stocktwits overview notes that RBC Capital analyst Deane Dray lifted the firm’s price target on 3M to USD 132 from USD 123 but maintained an Underperform rating, while Bernstein raised its target to USD 145 from USD 140 and also remained Underperform. Citi raised its price target to USD 183 from USD 166 with a Neutral stance, citing improving earnings momentum and the raised 2026 financial outlook as supporting factors. This spread of targets, from USD 132 to USD 218, shows that even after the EPS beat and guidance uplift, some analysts still see valuation risks or execution challenges alongside the upside arguments.
Risks and investor considerations
The combination of Eurobond issuance, raised guidance and diverse analyst opinions also surfaces key risks and counter-factors that investors in 3M stock need to consider. While Q2 2026 organic growth of 5.4 percent and the EPS beat of USD 0.42 versus consensus underline operational strength, the one-month share price decline of 9.68 percent highlighted by Dealroom suggests that short-term sentiment has been cautious, possibly reflecting broader market worries or lingering concerns around litigation, cyclical demand or cost pressures.
Furthermore, the fact that both RBC Capital and Bernstein maintain Underperform ratings, even as they lift their price targets to USD 132 and USD 145 respectively, underscores that some analysts still see downside risk relative to their view of fair value or sector alternatives. For longer-term shareholders, this mix of positive and cautious signals means the new Eurobond funding and higher guidance are best interpreted as parts of a larger restructuring and growth story, rather than a simple, one-directional catalyst.
Stock price and trading context
Based on recent market data for the 3M Company ticker MMM on its primary listing at the New York Stock Exchange, the shares most recently closed near USD 164.97 with the valuation comparison referenced above, as of the last completed trading day before September 13, 2026. In that context, the implied discount of about 10.3 percent versus the USD 181.85 fair-value estimate cited by Dealroom highlights that 3M stock trades below at least some modeled intrinsic-value benchmarks while still reflecting a year-to-date gain of around 6 percent as noted by Stocktwits.
Key data on 3M stock
- Company: 3M Company
- ISIN: US88579Y1010
- Ticker: MMM
- Trading venue: NYSE
- Price (as of September 12, 2026): 164.97 USD
- Market capitalization: [value] USD (as of September 12, 2026)
- Sector / Industry: Industrials / Diversified industrials
- Index membership: S&P 500
